PRNewsWire
23 Jun 2026, 10:50 UTC · 2h ago
BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
PRNewsWire
23 Jun 2026, 10:50 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
BD's CentroVena One™ Insertion System was awarded an Innovative Technology contract from Vizient, the largest provider-driven healthcare performance improvement company in the U.S. — Securing a contract with a major GPO like Vizient provides a direct pathway to a vast network of hospitals and significantly increases the potential for commercial adoption.
+0.40The CentroVena One™ system is an all-in-one design that reduces central line insertion steps by 30% and maximum procedure time by 50% compared to standard techniques. — Significant efficiency gains and a reduction in procedural error risks create a competitive advantage and a stronger value proposition for healthcare providers.
+0.20Which stocks this story touches
The company's CentroVena One system was awarded an Innovative Technology contract by Vizient, validating its innovation and expanding market access.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
13h ago
